Veracyte, Inc. (VCYT) Stock Price & Analysis
Veracyte, Inc. (VCYT) fell 4.79% to USD 42.53 as of September 8, 2026 at 09:36 UTC, according to Nexqual real-time market data.
VCYT last closed at USD 42.53; the session ranged USD 42.43–44.81 on volume of 992,183 shares. Market capitalization is —, with a 52-week range of USD 29.46–60.91 (NGM). Source: Nexqual, September 8, 2026 at 09:36 UTC.
Key Statistics (as of September 8, 2026 at 09:36 UTC)
| Price | USD 42.53 |
|---|---|
| Change | ▼ 4.79% (down) |
| Previous Close | USD 42.53 |
| Open | USD 42.53 |
| Day Range | USD 42.43 – 44.81 |
| 52-Week Range | USD 29.46 – 60.91 |
| Volume | 992,183 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (VCYT)
Nexqual's technical model rates VCYT "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:36 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 36.31 (neutral) |
| vs SMA50 | Below (USD 50.71) |
| MACD | -1.6 (negative) |
From Veracyte, Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Key Strengths & Strategy (as disclosed to the SEC)
- We rely on sole suppliers for critical supply of reagents, equipment and other materials and services that we use to perform our CLIA tests as well as to satisfy demand for our Prosigna test kits, service kits and service on the nCounter Analysis System.
- Certain of our products are regulated as IVD MDs, including Prosigna and the nCounter Analysis System.
- While we have developed alternate sourcing strategies for many materials, vendors and service providers, we cannot be certain whether these strategies will be effective or the alternative sources will be available when we need them.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CDNA | CareDx, Inc. | USD 50.88 | ▲ 2.58% |
| TWST | Twist Bioscience Corporation | USD 124.72 | ▼ 4.79% |
| FATE | Fate Therapeutics, Inc. | USD 2.48 | ▲ 1.22% |
| TXG | 10x Genomics, Inc. | USD 62.65 | ▲ 1.62% |
| PSNL | Personalis, Inc. | USD 17.2 | ▲ 2.81% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:36 UTC. This page is informational and not investment advice.